189 related articles for article (PubMed ID: 29163707)
1. N-Myc downstream-regulated gene 2 restrains glycolysis and glutaminolysis in clear cell renal cell carcinoma.
Shi W; Xu X; Yan F; Wang B; Zhao H; Chan A; Ren Z; Ma Y; Wang F; Yuan J
Oncol Lett; 2017 Dec; 14(6):6881-6887. PubMed ID: 29163707
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
[TBL] [Abstract][Full Text] [Related]
3. NDRG2 ablation reprograms metastatic cancer cells towards glutamine dependence
Ding M; Bu X; Li Z; Xu H; Feng L; Hu J; Wei X; Gao J; Tao Y; Cai B; Liu Y; Qu X; Shen L
Int J Biol Sci; 2020; 16(16):3100-3115. PubMed ID: 33162818
[No Abstract] [Full Text] [Related]
4. NDRG2 inhibition of glycolysis in liver tumor cells is regulated by SIRT1.
Zhang L; Kang J; Xin B; Cao W
J Gastrointest Oncol; 2023 Apr; 14(2):563-571. PubMed ID: 37201050
[TBL] [Abstract][Full Text] [Related]
5. Expression of NDRG2 in clear cell renal cell carcinoma.
Ma J; Jin H; Wang H; Yuan J; Bao T; Jiang X; Zhang W; Zhao H; Yao L
Biol Pharm Bull; 2008 Jul; 31(7):1316-20. PubMed ID: 18591767
[TBL] [Abstract][Full Text] [Related]
6. Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells.
Sharma BK; Kolhe R; Black SM; Keller JR; Mivechi NF; Satyanarayana A
FASEB J; 2016 Jan; 30(1):262-75. PubMed ID: 26330493
[TBL] [Abstract][Full Text] [Related]
7. Colorectal Cancer Cell Differentiation Is Dependent on the Repression of Aerobic Glycolysis by NDRG2-TXNIP Axis.
Hu J; Feng L; Ren M; Zhao Y; Lu G; Lu X; Li Y; Wang X; Bu X; Wang S; Shen L; He S
Dig Dis Sci; 2022 Aug; 67(8):3763-3772. PubMed ID: 34373985
[TBL] [Abstract][Full Text] [Related]
8. NDRG2 overexpression suppresses hepatoma cells survival during metabolic stress through disturbing the activation of fatty acid oxidation.
Pan T; Zhang M; Zhang F; Yan G; Ru Y; Wang Q; Zhang Y; Wei X; Xu X; Shen L; Zhang J; Wu K; Yao L; Li X
Biochem Biophys Res Commun; 2017 Feb; 483(2):860-866. PubMed ID: 28069379
[TBL] [Abstract][Full Text] [Related]
9. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
[TBL] [Abstract][Full Text] [Related]
10. Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma.
Liu R; Li Y; Tian L; Shi H; Wang J; Liang Y; Sun B; Wang S; Zhou M; Wu L; Nie J; Lin B; Tang S; Zhang Y; Wang G; Zhang C; Han J; Xu B; Liu L; Gong K; Zheng T
Cancer Lett; 2019 Feb; 443():34-46. PubMed ID: 30503555
[TBL] [Abstract][Full Text] [Related]
11. Suppression of microRNA-454 impedes the proliferation and invasion of prostate cancer cells by promoting N-myc downstream-regulated gene 2 and inhibiting WNT/β-catenin signaling.
Fu Q; Gao Y; Yang F; Mao T; Sun Z; Wang H; Song B; Li X
Biomed Pharmacother; 2018 Jan; 97():120-127. PubMed ID: 29080452
[TBL] [Abstract][Full Text] [Related]
12. Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2.
Xiao D; Ren P; Su H; Yue M; Xiu R; Hu Y; Liu H; Qing G
Oncotarget; 2015 Dec; 6(38):40655-66. PubMed ID: 26528759
[TBL] [Abstract][Full Text] [Related]
13. HSP60 silencing promotes Warburg-like phenotypes and switches the mitochondrial function from ATP production to biosynthesis in ccRCC cells.
Teng R; Liu Z; Tang H; Zhang W; Chen Y; Xu R; Chen L; Song J; Liu X; Deng H
Redox Biol; 2019 Jun; 24():101218. PubMed ID: 31112866
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
[TBL] [Abstract][Full Text] [Related]
15. c-Myc modulates glucose metabolism via regulation of miR-184/PKM2 pathway in clear-cell renal cell carcinoma.
Huang J; Kong W; Zhang J; Chen Y; Xue W; Liu D; Huang Y
Int J Oncol; 2016 Oct; 49(4):1569-75. PubMed ID: 27431728
[TBL] [Abstract][Full Text] [Related]
16. Malate dehydrogenase-2 inhibitor LW6 promotes metabolic adaptations and reduces proliferation and apoptosis in activated human T-cells.
Eleftheriadis T; Pissas G; Antoniadi G; Liakopoulos V; Stefanidis I
Exp Ther Med; 2015 Nov; 10(5):1959-1966. PubMed ID: 26640580
[TBL] [Abstract][Full Text] [Related]
17. Indoleamine 2,3-dioxygenase increases p53 levels in alloreactive human T cells, and both indoleamine 2,3-dioxygenase and p53 suppress glucose uptake, glycolysis and proliferation.
Eleftheriadis T; Pissas G; Antoniadi G; Spanoulis A; Liakopoulos V; Stefanidis I
Int Immunol; 2014 Dec; 26(12):673-84. PubMed ID: 25064493
[TBL] [Abstract][Full Text] [Related]
18. Yap-Myc signaling induces pancreatic stellate cell activation through regulating glutaminolysis.
Zhang D; Zhao L; Luo M; Lei J; Shao S
Exp Cell Res; 2022 Feb; 411(1):113000. PubMed ID: 34958764
[TBL] [Abstract][Full Text] [Related]
19. The platelet isoform of phosphofructokinase contributes to metabolic reprogramming and maintains cell proliferation in clear cell renal cell carcinoma.
Wang J; Zhang P; Zhong J; Tan M; Ge J; Tao L; Li Y; Zhu Y; Wu L; Qiu J; Tong X
Oncotarget; 2016 May; 7(19):27142-57. PubMed ID: 27049827
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Glycolysis and Glutaminolysis: An Emerging Drug Discovery Approach to Combat Cancer.
Akins NS; Nielson TC; Le HV
Curr Top Med Chem; 2018; 18(6):494-504. PubMed ID: 29788892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
